Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Curran

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Applied Clinical Medical Physics|December 25, 2015
Automated population-based planning for whole brain radiation therapyEduard Schreibmann, Tim Fox, Walter Curran, et al.
Medical Physics|January 10, 2013
Voxel clustering for quantifying PET-based treatment response assessmentEduard Schreibmann, Anthony F Waller, Ian Crocker, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Prognostic value of H-MLH1 after adjusting for RPA class in GBM patientsAli Choucair, Jennifer Moughan, Chris Schultz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2007
A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG databasePaul W Sperduto, Brian Berkey, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2015
Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical TrialsDeborah Watkins Bruner, Stephanie L Pugh, Katherine A Yeager, et al.
Neuro-Oncology|February 18, 2015
Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525Meihua Wang, James J Dignam, Minhee Won, et al.
International Journal of Radiation Oncology, Biology, Physics|June 18, 2018
Attrition in NRG Oncology's Radiation-Based Clinical TrialsConnie M Ulrich, Snehal Deshmukh, Stephanie L Pugh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancerHak Choy, Anshu K Jain, Jennifer Moughan, et al.
Clinical Lung Cancer|May 5, 2010
Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II studyDaniel Chua, Maciej Krzakowski, Christos Chouaid, et al.
American Journal of Clinical Oncology|June 24, 2009
Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastasesAndre Konski, Jennifer James, William Hartsell, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Applied Clinical Medical Physics|December 25, 2015
Automated population-based planning for whole brain radiation therapyEduard Schreibmann, Tim Fox, Walter Curran, et al.
Medical Physics|January 10, 2013
Voxel clustering for quantifying PET-based treatment response assessmentEduard Schreibmann, Anthony F Waller, Ian Crocker, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Prognostic value of H-MLH1 after adjusting for RPA class in GBM patientsAli Choucair, Jennifer Moughan, Chris Schultz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2007
A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG databasePaul W Sperduto, Brian Berkey, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2015
Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical TrialsDeborah Watkins Bruner, Stephanie L Pugh, Katherine A Yeager, et al.
Neuro-Oncology|February 18, 2015
Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525Meihua Wang, James J Dignam, Minhee Won, et al.
International Journal of Radiation Oncology, Biology, Physics|June 18, 2018
Attrition in NRG Oncology's Radiation-Based Clinical TrialsConnie M Ulrich, Snehal Deshmukh, Stephanie L Pugh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2008
RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancerHak Choy, Anshu K Jain, Jennifer Moughan, et al.
Clinical Lung Cancer|May 5, 2010
Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II studyDaniel Chua, Maciej Krzakowski, Christos Chouaid, et al.
American Journal of Clinical Oncology|June 24, 2009
Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastasesAndre Konski, Jennifer James, William Hartsell, et al.
Pageof 4